Cargando…

Miscarriage Treatment–Related Morbidities and Adverse Events in Hospitals, Ambulatory Surgery Centers, and Office-Based Settings

The aim of the study was to examine whether miscarriage treatment–related morbidities and adverse events vary across facility types. METHODS: A retrospective cohort study compared miscarriage treatment–related morbidities and adverse events across hospitals, ambulatory surgery centers (ASCs), and of...

Descripción completa

Detalles Bibliográficos
Autores principales: Roberts, Sarah C. M., Beam, Nancy, Liu, Guodong, Upadhyay, Ushma D., Leslie, Douglas L., Ba, Djibril, Kerns, Jennifer L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678655/
https://www.ncbi.nlm.nih.gov/pubmed/30516583
http://dx.doi.org/10.1097/PTS.0000000000000553
_version_ 1783612202331144192
author Roberts, Sarah C. M.
Beam, Nancy
Liu, Guodong
Upadhyay, Ushma D.
Leslie, Douglas L.
Ba, Djibril
Kerns, Jennifer L.
author_facet Roberts, Sarah C. M.
Beam, Nancy
Liu, Guodong
Upadhyay, Ushma D.
Leslie, Douglas L.
Ba, Djibril
Kerns, Jennifer L.
author_sort Roberts, Sarah C. M.
collection PubMed
description The aim of the study was to examine whether miscarriage treatment–related morbidities and adverse events vary across facility types. METHODS: A retrospective cohort study compared miscarriage treatment–related morbidities and adverse events across hospitals, ambulatory surgery centers (ASCs), and office-based settings. Data on women who had miscarriage treatment between 2011 and 2014 and were continuously enrolled in their insurance plan for at least 1 year before and at least 6 weeks after treatment were obtained from a large national private insurance claims database. The main outcome was miscarriage treatment–related morbidities and adverse events occurring within 6 weeks of miscarriage treatment. Secondary outcomes were major events and infections. RESULTS: A total of 97,374 miscarriage treatments met inclusion criteria. Most (75%) were provided in hospitals, 10% ASCs, and 15% office-based settings. A total of 9.3% had miscarriage treatment–related events, 1.0% major events, and 1.5% infections. In adjusted analyses, there were fewer events in ASCs (6.5%) than office-based settings (9.4%) and hospitals (9.6%), but no significant difference between office-based settings and hospitals. There were no significant differences in major events between ASCs (0.7%) and office-based settings (0.8%), but more in hospitals (1.1%) than ASCs and office-based settings. There were fewer infections in ASCs (0.9%) than office-based settings (1.2%) and more in hospitals (1.6%) than ASCs and office-based settings. In analyses stratified by miscarriage treatment type, the difference between ASCs and office-based settings was no longer significant for miscarriages treated with procedures. CONCLUSIONS: Although there seem to be slightly more events in hospitals than ASCs or office-based settings, findings do not support limiting miscarriage treatment to particular settings.
format Online
Article
Text
id pubmed-7678655
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-76786552020-11-23 Miscarriage Treatment–Related Morbidities and Adverse Events in Hospitals, Ambulatory Surgery Centers, and Office-Based Settings Roberts, Sarah C. M. Beam, Nancy Liu, Guodong Upadhyay, Ushma D. Leslie, Douglas L. Ba, Djibril Kerns, Jennifer L. J Patient Saf Original Articles The aim of the study was to examine whether miscarriage treatment–related morbidities and adverse events vary across facility types. METHODS: A retrospective cohort study compared miscarriage treatment–related morbidities and adverse events across hospitals, ambulatory surgery centers (ASCs), and office-based settings. Data on women who had miscarriage treatment between 2011 and 2014 and were continuously enrolled in their insurance plan for at least 1 year before and at least 6 weeks after treatment were obtained from a large national private insurance claims database. The main outcome was miscarriage treatment–related morbidities and adverse events occurring within 6 weeks of miscarriage treatment. Secondary outcomes were major events and infections. RESULTS: A total of 97,374 miscarriage treatments met inclusion criteria. Most (75%) were provided in hospitals, 10% ASCs, and 15% office-based settings. A total of 9.3% had miscarriage treatment–related events, 1.0% major events, and 1.5% infections. In adjusted analyses, there were fewer events in ASCs (6.5%) than office-based settings (9.4%) and hospitals (9.6%), but no significant difference between office-based settings and hospitals. There were no significant differences in major events between ASCs (0.7%) and office-based settings (0.8%), but more in hospitals (1.1%) than ASCs and office-based settings. There were fewer infections in ASCs (0.9%) than office-based settings (1.2%) and more in hospitals (1.6%) than ASCs and office-based settings. In analyses stratified by miscarriage treatment type, the difference between ASCs and office-based settings was no longer significant for miscarriages treated with procedures. CONCLUSIONS: Although there seem to be slightly more events in hospitals than ASCs or office-based settings, findings do not support limiting miscarriage treatment to particular settings. Lippincott Williams & Wilkins 2020-12 2018-12-04 /pmc/articles/PMC7678655/ /pubmed/30516583 http://dx.doi.org/10.1097/PTS.0000000000000553 Text en Copyright © 2018 The Author(s). Published by Wolters Kluwer Health, Inc. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Original Articles
Roberts, Sarah C. M.
Beam, Nancy
Liu, Guodong
Upadhyay, Ushma D.
Leslie, Douglas L.
Ba, Djibril
Kerns, Jennifer L.
Miscarriage Treatment–Related Morbidities and Adverse Events in Hospitals, Ambulatory Surgery Centers, and Office-Based Settings
title Miscarriage Treatment–Related Morbidities and Adverse Events in Hospitals, Ambulatory Surgery Centers, and Office-Based Settings
title_full Miscarriage Treatment–Related Morbidities and Adverse Events in Hospitals, Ambulatory Surgery Centers, and Office-Based Settings
title_fullStr Miscarriage Treatment–Related Morbidities and Adverse Events in Hospitals, Ambulatory Surgery Centers, and Office-Based Settings
title_full_unstemmed Miscarriage Treatment–Related Morbidities and Adverse Events in Hospitals, Ambulatory Surgery Centers, and Office-Based Settings
title_short Miscarriage Treatment–Related Morbidities and Adverse Events in Hospitals, Ambulatory Surgery Centers, and Office-Based Settings
title_sort miscarriage treatment–related morbidities and adverse events in hospitals, ambulatory surgery centers, and office-based settings
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678655/
https://www.ncbi.nlm.nih.gov/pubmed/30516583
http://dx.doi.org/10.1097/PTS.0000000000000553
work_keys_str_mv AT robertssarahcm miscarriagetreatmentrelatedmorbiditiesandadverseeventsinhospitalsambulatorysurgerycentersandofficebasedsettings
AT beamnancy miscarriagetreatmentrelatedmorbiditiesandadverseeventsinhospitalsambulatorysurgerycentersandofficebasedsettings
AT liuguodong miscarriagetreatmentrelatedmorbiditiesandadverseeventsinhospitalsambulatorysurgerycentersandofficebasedsettings
AT upadhyayushmad miscarriagetreatmentrelatedmorbiditiesandadverseeventsinhospitalsambulatorysurgerycentersandofficebasedsettings
AT lesliedouglasl miscarriagetreatmentrelatedmorbiditiesandadverseeventsinhospitalsambulatorysurgerycentersandofficebasedsettings
AT badjibril miscarriagetreatmentrelatedmorbiditiesandadverseeventsinhospitalsambulatorysurgerycentersandofficebasedsettings
AT kernsjenniferl miscarriagetreatmentrelatedmorbiditiesandadverseeventsinhospitalsambulatorysurgerycentersandofficebasedsettings